Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

× No keyword cloud information.

6 in total

1. Influence of GLP-1 receptor agonist on insulin dosage and blood glucose control of patients with type 2 diabetes mellitus.

Authors: Yimei Shen; Xiaohua Yang; Xiaojun Han; Wei Xi; Lihua Jiang; Shuqin Wang; Haifeng Zhong; Yunjuan Gu
Journal: Am J Transl Res Date: 2021-10-15 Impact factor: 4.060

2. Efficacy of epalrestat combined with alprostadil for diabetic nephropathy and its impacts on renal fibrosis and related factors of inflammation and oxidative stress.

Authors: Yanan Zhou; Rongrong Wang; Fengmei Han; Jincheng Zhang
Journal: Am J Transl Res Date: 2022-05-15 Impact factor: 3.940

3. Effect of high-quality nursing on blood glucose level, psychological state, and treatment compliance of patients with gestational diabetes mellitus.

Authors: Jiaoli Zou; Jinhua Huang
Journal: Am J Transl Res Date: 2021-11-15 Impact factor: 4.060

4. Galectin-3 Inhibition Ameliorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice.

Authors: Ning Zhu; Liuyan Zhu; Bingwu Huang; Wenjun Xiang; Xuyong Zhao
Journal: Front Cardiovasc Med Date: 2022-04-26

5. Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China.

Authors: Hao Zhaohu; Huang Xiao; Shao Hailin; He Feng
Journal: J Diabetes Res Date: 2022-08-13 Impact factor: 4.061

6. Cost-Effectiveness Analysis of Dapagliflozin Plus Standard Treatment for Patients With Type 2 Diabetes and High Risk of Cardiovascular Disease in China.

Authors: Kaiyu Huang; Yao Wang; Sijia Sun; Qian Zhu; Weifeng Zhou; Jiatao Liu; Dongchun Zhu; Xuefeng Xie
Journal: Front Public Health Date: 2022-07-13

6 in total